ViiV Healthcare submits extended approval request for tablet formulation of Triumeq for HIV to FDA
ViiV Healthcare has announced it has made a regulatory submission to the FDA for approval of a new dispersible tablet formulation of the fixed dose combination of abacavir,… read more.